BioHarvest Sciences Inc.

CNSX:BHSC Stock Report

Market Cap: CA$152.5m

BioHarvest Sciences Management

Management criteria checks 3/4

BioHarvest Sciences' CEO is Ilan Sobel, appointed in Jun 2020, has a tenure of 4.58 years. directly owns 1.25% of the company’s shares, worth CA$1.91M. The average tenure of the management team and the board of directors is 3.7 years and 4 years respectively.

Key information

Ilan Sobel

Chief executive officer

US$481.6k

Total compensation

CEO salary percentagen/a
CEO tenure4.6yrs
CEO ownership1.3%
Management average tenure3.7yrs
Board average tenure4yrs

Recent management updates

Recent updates

Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26%

Nov 17
Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26%

BioHarvest Sciences Inc.'s (CSE:BHSC) P/S Is On The Mark

Mar 17
BioHarvest Sciences Inc.'s (CSE:BHSC) P/S Is On The Mark

Investors Interested In BioHarvest Sciences Inc.'s (CSE:BHSC) Revenues

Dec 01
Investors Interested In BioHarvest Sciences Inc.'s (CSE:BHSC) Revenues

Don't Ignore The Fact That This Insider Just Sold Some Shares In BioHarvest Sciences Inc. (CSE:BHSC)

Jan 17
Don't Ignore The Fact That This Insider Just Sold Some Shares In BioHarvest Sciences Inc. (CSE:BHSC)

How Much Of BioHarvest Sciences Inc. (CSE:BHSC) Do Insiders Own?

Jan 10
How Much Of BioHarvest Sciences Inc. (CSE:BHSC) Do Insiders Own?

CEO

Ilan Sobel

4.6yrs

Tenure

US$481,581

Compensation

Mr. Ilan Sobel has been the Chief Executive Officer at BioHarvest Sciences Inc. since June 9, 2020. He served as Chief Operating Officer at Weissbeerger Ltd. and then Chief Commercial Officer of Weissbeerg...


Leadership Team

NamePositionTenureCompensationOwnership
Zaki Rakib
Co-Founder6.3yrsUS$1.16mno data
Ilan Sobel
Chief Executive Officer4.6yrsUS$481.58k1.25%
CA$ 1.9m
Yochi Hagay
Co-Founder6.3yrsUS$67.02k0.18%
CA$ 279.0k
Ilana Belzer
Chief Operating Officer1.8yrsUS$275.09k0.0032%
CA$ 4.8k
David Ryan
VP of Investor Relations & Secretary11.8yrsUS$44.45k0.23%
CA$ 343.3k
Brian Cornblatt
Chief Medical Officer & Member of Scientific Advisory Board2.8yrsUS$421.35k0.015%
CA$ 22.6k
Bar Dichter
Chief Financial Officerless than a yearno datano data
Matthew Zrebiec
Vice President of Business Developmentless than a yearno datano data

3.7yrs

Average Tenure

64.5yo

Average Age

Experienced Management: BHSC's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zaki Rakib
Co-Founder6.3yrsUS$1.16mno data
Yochi Hagay
Co-Founder4yrsUS$67.02k0.18%
CA$ 279.0k
Brian Cornblatt
Chief Medical Officer & Member of Scientific Advisory Board2yrsUS$421.35k0.015%
CA$ 22.6k
Steven Lehrer
Member of Board of Advisor3.3yrsno datano data
Vincent Giampapa
Member of Scientific Advisory Boardno datano datano data
Dennis Goodman
Member of Scientific Advisory Board4yrsno datano data
David Tsur
Independent Non-Executive Director3.3yrsUS$37.36kno data
David Brady
Member of Scientific Advisory Board4.3yrsno datano data
Scott McCune
Member of Advisory Board3.8yrsno datano data
Vivien Rakib
Independent Director6.3yrsUS$26.65k17.5%
CA$ 26.7m
John Fiddick
Independent Director5.9yrsUS$26.65kno data
Roberto Chait
Member of Advisory Board4.3yrsno datano data

4.0yrs

Average Tenure

66yo

Average Age

Experienced Board: BHSC's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 09:23
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioHarvest Sciences Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC
Amit DayalH.C. Wainwright & Co.
Anthony VendettiMaxim Group